Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export
2021; Adis, Springer Healthcare; Linguagem: Inglês
10.1007/s40262-021-01016-y
ISSN1179-1926
AutoresJustin Bader, Albiruni Ryan Abdul Razak, Sharon Shacham, Hongmei Xu,
Tópico(s)Cancer-related Molecular Pathways
Referência(s)